BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Cancer / Oncology

How Optoacoustic Imaging Plays a Role in Assessing the Success of Breast Cancer Surgery

This first-in-human study was carried out by a team of researchers and clinicians at A*STAR’s Institute of Bioengineering and Bioimaging (IBB)&...

December 05, 2022 | News

Propanc Biopharma Concludes PRP Could Become an Effective Chemosensitizer Agent Against Pancreatic Cancer

Propanc Biopharma, Inc. (OTC Pink: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel cancer tre...

December 02, 2022 | News

BioVaxys Announces Successful Test-Run Production of its Bi-Haptenized Ovarian Cancer Vaccine

The complete manufacturing of BVX-0918 from a cancer patient's ovarian tumor now validates the production protocols that had been in development over the p...

December 02, 2022 | News

GE Healthcare Highlights Transformative Precision Innovations and Collaborations that Help Drive the Future of Health

Drawing on more than 100 years of history as a trusted medical technology innovator1, GE Healthcare is closely connected with healthcare systems globally. ...

November 28, 2022 | News

Merck Aims to Double R&D Productivity in Oncology, Neurology and Immunology to Deliver more Medicines to Patients Faster

Company aims to launch one new product or indication every 1.5 years on average, bolstered by external innovation Phase III assets xevinapant and evobru...

November 23, 2022 | News

GSK opens first-in-Singapore high potency manufacturing and testing facility for next generation cancer treatments

S$44m investment in the new high potency manufacturing facility and laboratory further strengthens Jurong site capabilities to launch new products more q...

November 21, 2022 | News

Swedish and Jordanian royalty inaugurate Elekta radiation therapy devices for cancer and brain disease

Dignitaries from Sweden and Jordan attended the inauguration of two of Elekta’s (EKTA-B.ST) cancer care technologies, including an advanced linear ac...

November 18, 2022 | News

Lunit to Supply AI Platform to Australia's BreastScreen NSW Machine Reading Project

Lunit's INSIGHT MMG solution has been selected for mammogram screening in Australia's BreastScreen NSW's AI evaluation and clinical integration...

November 17, 2022 | News

Telix Announces Positive Topline Results of ZIRCON Phase III Kidney Cancer Imaging Study

Summary of Study Outcomes ZIRCON Phase III study of Telix's investigational imaging agent TLX250-CDx in clear cell renal cell carcinoma (ccRCC) has met ...

November 07, 2022 | News

Hexvix®, A Diagnostic Drug for Bladder Cancer of Asieris, Completed the First Patient Dose in Phase III Trial

The study is a prospective, self-controlled, multicenter Phase Ⅲ trial aimed at investigating the additional detection rate and safety of Hexvix®&nbs...

November 07, 2022 | News

Australia First in-human use of OncoRes Medical's cancer imaging system successful

OncoRes Medical today announces positive data from the first in-cavity use of its Quantitative Micro-Elastography (QME) Imaging System. The study, titled&n...

November 03, 2022 | News

Exact Sciences Applauds Proposed CMS Change to Colorectal Cancer Screening Policy

If adopted, the rule would eliminate all cost to Medicare patients for a follow-up colonoscopy after a positive at-home colorectal cancer screening test. A...

November 02, 2022 | News

Irish oncology care platform announces collaboration with NCCN

The Irish-founded oncology software company, ONCOassist, today announces a new agreement with The National Comprehensive Cancer Network® (NCCN®). T...

October 18, 2022 | News

Chinese NMPA Approves Pivotal Phase III Study of TLX591-CDx for Prostate Cancer Imaging

The IND application was submitted in partnership with Grand Pharmaceutical Group Limited (Grand Pharma), Telix's partner in the Greater China reg...

October 17, 2022 | News

Stay Connected